KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifeward (LFWD) Cash & Equivalents (2016 - 2025)

Lifeward's Cash & Equivalents history spans 12 years, with the latest figure at $2.0 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 81.64% year-over-year to $2.0 million; the TTM value through Sep 2025 reached $2.0 million, down 81.64%, while the annual FY2024 figure was $6.7 million, 75.98% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $2.0 million at Lifeward, down from $5.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $91.2 million in Q3 2021 and bottomed at $2.0 million in Q3 2025.
  • The 5-year median for Cash & Equivalents is $58.2 million (2023), against an average of $45.3 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 405.41% in 2021 before it crashed 81.64% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $88.3 million in 2021, then fell by 23.14% to $67.9 million in 2022, then plummeted by 58.64% to $28.1 million in 2023, then tumbled by 75.98% to $6.7 million in 2024, then plummeted by 71.01% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for LFWD's Cash & Equivalents are $2.0 million (Q3 2025), $5.1 million (Q2 2025), and $5.7 million (Q1 2025).